ANTIBODY TARGETING IL-13RA2 AND USE THEREOF
- 专利权人:
- LTD.;CARSGEN THERAPEUTICS CO.
- 发明人:
- Peng WANG,Huamao WANG
- 申请号：
- US16486481
- 公开号：
- US20190359723A1
- 申请日:
- 2018.02.08
- 申请国别(地区):
- US
- 年份:
- 2019
- 代理人:
- 摘要：
- Provided is an antibody that specifically recognizes IL-13RA2, which can be used in the manufacture of a targeting anti-tumor medicament as well as a medicament for diagnosing a tumor.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- MEDICAMENT FOR TREATMENT OF A TUMOR COMPRISING A ENDOSTATIN AND POLYETHYLENE GLYCOL CONJUGATE
- ANTI-CANCER ORAL LIQUID PREPARATIONS AND METHOD FOR MANUFACTURING ESSENTIAL INGREDIENTS THEREOF
- IMMUNOMODULATORY ORAL LIQUID PREPARATIONS HAVING ANTI-CANCER EFFICACY AND METHOD FOR MANUFACTURING ESSENTIAL INGREDIENTS THEREOF
- Application and drugs of isovaleryl spiramycin I, II and / or III in the manufacture of drugs to treat and / or prevent tumors
- MEDICAMENT FOR TREATMENT OF TUMOR AND THE USE THEREOF
